Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 6 studies | 25% ± 5% | |
epithelial cell | 6 studies | 29% ± 11% | |
plasma cell | 5 studies | 29% ± 9% | |
adipocyte | 5 studies | 23% ± 5% | |
fibroblast | 5 studies | 21% ± 4% | |
GABAergic neuron | 4 studies | 32% ± 9% | |
astrocyte | 4 studies | 24% ± 6% | |
lymphocyte | 3 studies | 17% ± 1% | |
hepatocyte | 3 studies | 41% ± 30% | |
glutamatergic neuron | 3 studies | 45% ± 8% | |
oligodendrocyte precursor cell | 3 studies | 23% ± 6% | |
goblet cell | 3 studies | 45% ± 28% | |
transit amplifying cell | 3 studies | 22% ± 8% | |
oligodendrocyte | 3 studies | 20% ± 2% | |
microglial cell | 3 studies | 22% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 369.95 | 1441 / 1445 | 100% | 6.63 | 183 / 183 |
stomach | 100% | 379.00 | 358 / 359 | 100% | 7.83 | 286 / 286 |
intestine | 100% | 429.54 | 964 / 966 | 100% | 8.14 | 525 / 527 |
lung | 99% | 352.06 | 575 / 578 | 100% | 5.96 | 1151 / 1155 |
breast | 100% | 428.34 | 459 / 459 | 99% | 6.52 | 1104 / 1118 |
skin | 100% | 577.58 | 1808 / 1809 | 97% | 4.44 | 460 / 472 |
pancreas | 100% | 568.18 | 328 / 328 | 97% | 4.48 | 173 / 178 |
ovary | 99% | 218.87 | 179 / 180 | 97% | 3.64 | 419 / 430 |
bladder | 100% | 295.76 | 21 / 21 | 96% | 5.88 | 486 / 504 |
prostate | 100% | 323.60 | 245 / 245 | 95% | 4.61 | 476 / 502 |
kidney | 100% | 311.03 | 89 / 89 | 95% | 3.66 | 852 / 901 |
uterus | 100% | 274.57 | 170 / 170 | 92% | 4.06 | 423 / 459 |
thymus | 100% | 324.31 | 651 / 653 | 85% | 1.89 | 515 / 605 |
liver | 100% | 465.08 | 225 / 226 | 82% | 2.43 | 334 / 406 |
adrenal gland | 100% | 352.99 | 258 / 258 | 73% | 1.62 | 167 / 230 |
adipose | 100% | 435.29 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 295.95 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.52 | 1 / 1 |
blood vessel | 99% | 288.95 | 1327 / 1335 | 0% | 0 | 0 / 0 |
brain | 38% | 37.24 | 995 / 2642 | 62% | 1.22 | 435 / 705 |
tonsil | 0% | 0 | 0 / 0 | 93% | 3.47 | 42 / 45 |
heart | 91% | 195.33 | 785 / 861 | 0% | 0 | 0 / 0 |
muscle | 91% | 163.19 | 727 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 86% | 2.13 | 69 / 80 |
peripheral blood | 79% | 305.71 | 732 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 69% | 3.11 | 20 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006486 | Biological process | protein glycosylation |
GO_0006487 | Biological process | protein N-linked glycosylation |
GO_0009298 | Biological process | GDP-mannose biosynthetic process |
GO_0006013 | Biological process | mannose metabolic process |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0043025 | Cellular component | neuronal cell body |
GO_0004615 | Molecular function | phosphomannomutase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | PMM2 |
Protein name | Phosphomannomutase 2 (PMM 2) (EC 5.4.2.8) Phosphomannomutase (EC 5.4.2.8) |
Synonyms | |
Description | FUNCTION: Involved in the synthesis of the GDP-mannose and dolichol-phosphate-mannose required for a number of critical mannosyl transfer reactions. . FUNCTION: Involved in the synthesis of the GDP-mannose and dolichol-phosphate-mannose required for a number of critical mannosyl transfer reactions. . FUNCTION: Involved in the synthesis of the GDP-mannose and dolichol-phosphate-mannose required for a number of critical mannosyl transfer reactions. . FUNCTION: Involved in the synthesis of the GDP-mannose and dolichol-phosphate-mannose required for a number of critical mannosyl transfer reactions. . FUNCTION: Involved in the synthesis of the GDP-mannose and dolichol-phosphate-mannose required for a number of critical mannosyl transfer reactions. . FUNCTION: Involved in the synthesis of the GDP-mannose and dolichol-phosphate-mannose required for a number of critical mannosyl transfer reactions. . FUNCTION: Involved in the synthesis of the GDP-mannose and dolichol-phosphate-mannose required for a number of critical mannosyl transfer reactions. . FUNCTION: Involved in the synthesis of the GDP-mannose and dolichol-phosphate-mannose required for a number of critical mannosyl transfer reactions. . FUNCTION: Involved in the synthesis of the GDP-mannose and dolichol-phosphate-mannose required for a number of critical mannosyl transfer reactions. . FUNCTION: Involved in the synthesis of the GDP-mannose and dolichol-phosphate-mannose required for a number of critical mannosyl transfer reactions. . FUNCTION: Involved in the synthesis of the GDP-mannose and dolichol-phosphate-mannose required for a number of critical mannosyl transfer reactions. . FUNCTION: Involved in the synthesis of the GDP-mannose and dolichol-phosphate-mannose required for a number of critical mannosyl transfer reactions. . |
Accessions | ENST00000565896.5 A0A291FGD1 H3BNY9 H3BM92 ENST00000565221.5 H3BR08 ENST00000268261.9 [O15305-1] H3BPH4 ENST00000570076.5 A0A0S2Z4J6 ENST00000568602.5 H3BV55 ENST00000566604.5 [O15305-2] ENST00000564069.1 ENST00000566983.5 ENST00000683435.1 A0A804HKA7 ENST00000570134.5 ENST00000682008.1 ENST00000566540.5 H3BV34 ENST00000562318.5 ENST00000683094.1 ENST00000569958.5 H3BRM0 O15305 H3BT06 ENST00000683274.1 [O15305-2] ENST00000682393.1 |